Ortoma AB Series B (ORT-B) - Total Assets
Based on the latest financial reports, Ortoma AB Series B (ORT-B) holds total assets worth Skr161.34 Million SEK (≈ $17.36 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ORT-B net assets for net asset value and shareholders' equity analysis.
Ortoma AB Series B - Total Assets Trend (2021–2025)
This chart illustrates how Ortoma AB Series B's total assets have evolved over time, based on quarterly financial data.
Ortoma AB Series B - Asset Composition Analysis
Current Asset Composition (December 2025)
Ortoma AB Series B's total assets of Skr161.34 Million consist of 25.3% current assets and 74.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 12.9% |
| Accounts Receivable | Skr6.20 Million | 3.8% |
| Inventory | Skr8.57 Million | 5.3% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr119.98 Million | 74.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Ortoma AB Series B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Ortoma AB Series B.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ortoma AB Series B's current assets represent 25.3% of total assets in 2025, an increase from 13.4% in 2021.
- Cash Position: Cash and equivalents constituted 12.9% of total assets in 2025, up from 9.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 74.0% of total assets, a decrease from 86.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 74.4% of total assets.
Ortoma AB Series B Competitors by Total Assets
Key competitors of Ortoma AB Series B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $1.36 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥965.27 Million |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
Ortoma AB Series B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.19 | 3.01 | 3.80 |
| Quick Ratio | 1.73 | 2.47 | 3.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr22.23 Million | Skr32.51 Million | Skr38.43 Million |
Ortoma AB Series B - Advanced Valuation Insights
This section examines the relationship between Ortoma AB Series B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.77 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -10.9% |
| Total Assets | Skr161.34 Million |
| Market Capitalization | $39.18 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ortoma AB Series B's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Ortoma AB Series B's assets decreased by 10.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ortoma AB Series B (2021–2025)
The table below shows the annual total assets of Ortoma AB Series B from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr161.34 Million ≈ $17.36 Million |
-10.85% |
| 2024-12-31 | Skr180.98 Million ≈ $19.48 Million |
-5.90% |
| 2023-12-31 | Skr192.33 Million ≈ $20.70 Million |
+27.11% |
| 2022-12-31 | Skr151.31 Million ≈ $16.28 Million |
+12.93% |
| 2021-12-31 | Skr133.99 Million ≈ $14.42 Million |
-- |
About Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more